Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rossi

Showing results (981-990 of 1,061) with videos related to

Pageof 107
Sort By:
The American Journal of Gastroenterology|May 3, 2018
Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trialIbironke Oduyebo, Michael Camilleri, Alfred D Nelson, et al.
Brachytherapy|July 24, 2025
High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statementSagar A Patel, Marisa Kollmeier, Juanita Crook, et al.
Nature Biomedical Engineering|April 25, 2019
Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editingBruna S Paulsen, Pankaj K Mandal, Richard L Frock, et al.
American Journal of Clinical Oncology|November 22, 2011
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancerBrian J Moran, Paul DeRose, I-Chow Joe Hsu, et al.
Brachytherapy|November 2, 2020
The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assuranceSteven J Frank, Firas Mourtada, Juanita Crook, et al.
Molecular Therapy. Nucleic Acids|December 18, 2020
A Multifunctional LNA Oligonucleotide-Based Strategy Blocks AR Expression and Transactivation Activity in PCa CellsDaniela Castanotto, Xiaowei Zhang, Jacqueline Rüger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2019
Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized MiceJiehua Zhou, Haitang Li, Xin Xia, et al.
Journal of Vascular Surgery|November 26, 2025
The My PAD study for patient-reported outcomes for peripheral vascular intervention in the Vascular Quality InitiativeDaniel J Bertges, Matthew A Corriere, Jessica P Simons, et al.
Molecular Therapy. Nucleic Acids|February 4, 2022
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkersSi-Ping Han, Lisa Scherer, Matt Gethers, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthSorah Yoon, Kai-Wen Huang, Vikash Reebye, et al.
Pageof 107

Showing results (981-990 of 1,061) with videos related to

Sort By:
Pageof 107
The American Journal of Gastroenterology|May 3, 2018
Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trialIbironke Oduyebo, Michael Camilleri, Alfred D Nelson, et al.
Brachytherapy|July 24, 2025
High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statementSagar A Patel, Marisa Kollmeier, Juanita Crook, et al.
Nature Biomedical Engineering|April 25, 2019
Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editingBruna S Paulsen, Pankaj K Mandal, Richard L Frock, et al.
American Journal of Clinical Oncology|November 22, 2011
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancerBrian J Moran, Paul DeRose, I-Chow Joe Hsu, et al.
Brachytherapy|November 2, 2020
The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assuranceSteven J Frank, Firas Mourtada, Juanita Crook, et al.
Molecular Therapy. Nucleic Acids|December 18, 2020
A Multifunctional LNA Oligonucleotide-Based Strategy Blocks AR Expression and Transactivation Activity in PCa CellsDaniela Castanotto, Xiaowei Zhang, Jacqueline Rüger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2019
Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized MiceJiehua Zhou, Haitang Li, Xin Xia, et al.
Journal of Vascular Surgery|November 26, 2025
The My PAD study for patient-reported outcomes for peripheral vascular intervention in the Vascular Quality InitiativeDaniel J Bertges, Matthew A Corriere, Jessica P Simons, et al.
Molecular Therapy. Nucleic Acids|February 4, 2022
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkersSi-Ping Han, Lisa Scherer, Matt Gethers, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthSorah Yoon, Kai-Wen Huang, Vikash Reebye, et al.
Pageof 107